Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $45.8033 (3.04%) ($43.5781 - $46.3398) on Mon. Oct. 26, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.36% (three month average) | RSI | 44 | Latest Price | $45.8033(3.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.6% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(47%) IBB(46%) IVE(45%) SPY(45%) | Factors Impacting ABBV price | ABBV will decline at least -1.18% in a week (0% probabilities). VIXM(-20%) TLT(-14%) UUP(-10%) IGOV(-3%) GLD(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.18% (StdDev 2.36%) | Hourly BBV | 0 () | Intraday Trend | 3.4% | | | |
|
1 - 5 Day Possible Target | $39.17(-14.48%) | Resistance Level | $47.8 | 5 Day Moving Average | $45.77(0.07%) | 10 Day Moving Average | $47.22(-3%) | 20 Day Moving Average | $47.8(-4.18%) | To recent high | -26.5% | To recent low | 7.5% | Market Cap | $80.81b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |